Oral Semaglutide Cuts Cardiovascular Risk by 14% in SOUL Trial
Ticagrelor Antidote Bentracimab Safely Reverses Antiplatelet Effects in Phase 3 REVERSE-IT Trial
AI Is Changing the Landscape of Cardiovascular Care
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
